<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <source-app name="Horizon">Horizon</source-app>
      <rec-number>1</rec-number>
      <foreign-keys>
        <key app="Horizon" db-id="fdi:010040724">1</key>
      </foreign-keys>
      <ref-type name="Journal Article">17</ref-type>
      <work-type>ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES</work-type>
      <contributors>
        <authors>
          <author>
            <style face="normal" font="default" size="100%">Desrivot, J.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Herrenknecht, C.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Ponchel, G.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Garbi, N.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Prina, E.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Fournet, Alain</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Bories, C.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Figadère, B.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Hocquemiller, B.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Loiseau, P.M.</style>
          </author>
        </authors>
      </contributors>
      <titles>
        <title>Antileshmanial 2-substituted quinolines : in vitro behaviour towards biological components</title>
        <secondary-title>Biomedicine and Pharmacotherapy</secondary-title>
      </titles>
      <pages>441-450</pages>
      <keywords>
        <keyword>LEISHMANIOSE</keyword>
        <keyword>PARASITE</keyword>
        <keyword>METHODE DE LUTTE</keyword>
        <keyword>MEDICAMENT</keyword>
        <keyword>EFFICACITE</keyword>
        <keyword>EXPERIMENTATION IN VITRO</keyword>
        <keyword>CHROMATOGRAPHIE EN PHASE LIQUIDE</keyword>
        <keyword>EXTRACTION</keyword>
        <keyword>TEMPERATURE</keyword>
        <keyword>ETUDE EXPERIMENTALE</keyword>
        <keyword>ETUDE COMPARATIVE</keyword>
        <keyword>QUINOLINE</keyword>
        <keyword>PHARMACOCINETIQUE</keyword>
        <keyword>CYTOTOXICITE</keyword>
        <keyword>CONCENTRATION</keyword>
        <keyword>HEMATOCRITE</keyword>
      </keywords>
      <dates>
        <year>2007</year>
      </dates>
      <call-num>fdi:010040724</call-num>
      <language>ENG</language>
      <periodical>
        <full-title>Biomedicine and Pharmacotherapy</full-title>
      </periodical>
      <isbn>0750-3322</isbn>
      <accession-num>ISI:000249323900010</accession-num>
      <number>7</number>
      <urls>
        <related-urls>
          <url>https://www.documentation.ird.fr/hor/fdi:010040724</url>
        </related-urls>
        <pdf-urls>
          <url>https://www.documentation.ird.fr/intranet/publi/2007/10/010040724.pdf</url>
        </pdf-urls>
      </urls>
      <volume>61</volume>
      <remote-database-provider>Horizon (IRD)</remote-database-provider>
      <custom6>052PHLEIS03</custom6>
      <custom1>US084</custom1>
    </record>
  </records>
</xml>
